Exact Mass: 429.096081

Exact Mass Matches: 429.096081

Found 27 metabolites which its exact mass value is equals to given mass value 429.096081, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Besifloxacin HCl

Besifloxacin Hydrochloride

C19H22Cl2FN3O3 (429.1022174)


D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

trans-zeatin riboside monophosphate

(3,4-Dihydroxy-5-{6-[(4-hydroxy-3-methylbut-2-en-1-yl)amino]-9H-purin-9-yl}oxolan-2-yl)methyl phosphoric acid

C15H20N5O8P (429.10494500000004)


Cis-zeatin riboside monophosphate is a member of the class of compounds known as purine ribonucleoside monophosphates. Purine ribonucleoside monophosphates are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Cis-zeatin riboside monophosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Cis-zeatin riboside monophosphate can be found in a number of food items such as lichee, swiss chard, catjang pea, and teff, which makes cis-zeatin riboside monophosphate a potential biomarker for the consumption of these food products.

   
   

(2-DIMETHYLAMINO-4-NITROPHENYL) PHOSPHORIC ACID DIAMMONIUM SALT MONOHYDRATE

(2-DIMETHYLAMINO-4-NITROPHENYL) PHOSPHORIC ACID DIAMMONIUM SALT MONOHYDRATE

C8H25N5O11P2 (429.10257599999994)


   

4-nitrooxybutyl 2-(5-hydroxy-4-oxo-2-phenylchromen-7-yl)oxyacetate

4-nitrooxybutyl 2-(5-hydroxy-4-oxo-2-phenylchromen-7-yl)oxyacetate

C21H19NO9 (429.10597640000003)


   

N-(2-Benzoyl-4-nitrophenyl)-1,3-dihydro-1,3-dioxo-2H-isoindole-2-acetamide

N-(2-Benzoyl-4-nitrophenyl)-1,3-dihydro-1,3-dioxo-2H-isoindole-2-acetamide

C23H15N3O6 (429.096081)


   

Anthrimide

1,1-Iminodianthra-9,10-quinone

C28H15NO4 (429.10010300000005)


   

3-[N-(2-hydroxyethyl)-4-[(6-methylsulfonyl-1,3-benzothiazol-2-yl)diazenyl]anilino]propanenitrile

3-[N-(2-hydroxyethyl)-4-[(6-methylsulfonyl-1,3-benzothiazol-2-yl)diazenyl]anilino]propanenitrile

C19H19N5O3S2 (429.09292639999995)


   

Phosphonic acid, P,P-(dichloromethylene)bis-, compd. with N,N-dibutyl-1-butanamine (1:1)

Phosphonic acid, P,P-(dichloromethylene)bis-, compd. with N,N-dibutyl-1-butanamine (1:1)

C13H31Cl2NO6P2 (429.1003586)


   

(alphaZ)-5-Amino-alpha-[(triphenylmethoxy)imino]-1,2,4-thiadiazole-3-acetic acid ion(1-)

(alphaZ)-5-Amino-alpha-[(triphenylmethoxy)imino]-1,2,4-thiadiazole-3-acetic acid ion(1-)

C23H17N4O3S (429.10213120000003)


   

2-[3-(1H-imidazol-5-yl)propyl]-1-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine,trihydrochloride

2-[3-(1H-imidazol-5-yl)propyl]-1-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine,trihydrochloride

C14H26Cl3N7S (429.1035886000001)


   

4-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-N-(4,6-dimethyl-2-pyridinyl)-1-piperazinecarbothioamide

4-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-N-(4,6-dimethyl-2-pyridinyl)-1-piperazinecarbothioamide

C18H19ClF3N5S (429.10017200000004)


   

2-Furanyl-[4-[(6-hydroxy-2-methyl-5-thiazolo[3,2-b][1,2,4]triazolyl)-thiophen-2-ylmethyl]-1-piperazinyl]methanone

2-Furanyl-[4-[(6-hydroxy-2-methyl-5-thiazolo[3,2-b][1,2,4]triazolyl)-thiophen-2-ylmethyl]-1-piperazinyl]methanone

C19H19N5O3S2 (429.09292639999995)


   

(2-Mercaptomethyl-4-phenyl-butyrylimino)-(5-tetrazol-1-ylmethyl-thiophen-2-yl)-acetic acid

(2-Mercaptomethyl-4-phenyl-butyrylimino)-(5-tetrazol-1-ylmethyl-thiophen-2-yl)-acetic acid

C19H19N5O3S2 (429.09292639999995)


   
   

N-acetyl-L-aspartyl-L-glutamyl-L-glutamate

N-acetyl-L-aspartyl-L-glutamyl-L-glutamate

C16H19N3O11-4 (429.10195439999995)


   

[3,4-dihydroxy-5-[6-[[(E)-4-hydroxy-3-methylbut-2-enyl]amino]purin-9-yl]oxolan-2-yl]methyl phosphate

[3,4-dihydroxy-5-[6-[[(E)-4-hydroxy-3-methylbut-2-enyl]amino]purin-9-yl]oxolan-2-yl]methyl phosphate

C15H20N5O8P-2 (429.10494500000004)


   

N-(3-carbamoyl-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-3-(2-chlorophenyl)-5-methyl-4-isoxazolecarboxamide

N-(3-carbamoyl-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-3-(2-chlorophenyl)-5-methyl-4-isoxazolecarboxamide

C21H20ClN3O3S (429.09138400000006)


   

4-[(4-chlorophenyl)methyl-methylsulfonylamino]-N-(2-pyridinylmethyl)benzamide

4-[(4-chlorophenyl)methyl-methylsulfonylamino]-N-(2-pyridinylmethyl)benzamide

C21H20ClN3O3S (429.09138400000006)


   

2-chloro-N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-5-(1,2,4-triazol-4-yl)benzamide

2-chloro-N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-5-(1,2,4-triazol-4-yl)benzamide

C23H16ClN5O2 (429.0992466)


   

2-(2-Bromophenyl)-3-[3-(4-morpholinyl)propyl]-1,2-dihydroquinazolin-4-one

2-(2-Bromophenyl)-3-[3-(4-morpholinyl)propyl]-1,2-dihydroquinazolin-4-one

C21H24BrN3O2 (429.1051784)


   
   

9-Ribosyl-trans-zeatin 5-phosphate(2-)

9-Ribosyl-trans-zeatin 5-phosphate(2-)

C15H20N5O8P (429.10494500000004)


A organophosphate oxoanion that is that is AMP(2-) substituted at position N-6 by a (2E)-4-hydroxy-3-methylbut-2-en-1-yl group; major species at pH 7.3.

   

UBP316

UBP316

C20H19N3O6S (429.0994514000001)


UBP316 (ACET) is a highly potent and selective kainate receptor GluK1 (GluR5) antagonist, with a Kb value of 1.4 nM. UBP316 is effective at blocking the depression of both field excitatory postsynaptic potentials (fEPSPs) and monosynaptically-evoked GABAergic transmission induced by ATPA, a GluK1 selective agonist[1].